External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma
External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma
复制标题
DOI:
10.1136/thoraxjnl-2014-205634
复制
发表时间:
2015-02-01
期刊:
影响因子:
10
通讯作者:
Sterk, P. J.
中科院分区:
文献类型:
--
作者:
Wagener, A. H.;de Nijs, S. B.;Sterk, P. J.
Background Monitoring sputum eosinophils in asthma predicts exacerbations and improves management of asthma. Thus far, blood eosinophils and FENO show contradictory results in predicting eosinophilic airway inflammation. More recently, serum periostin was proposed as a novel biomarker for eosinophilic inflammation.Objectives Quantifying the mutual relationships of blood eosinophils, FENO, and serum periostin with sputum eosinophils by external validation in two independent cohorts across various severities of asthma.Methods The first cohort consisted of 110 patients with mild to moderate asthma (external validation cohort). The replication cohort consisted of 37 patients with moderate to severe asthma. Both cohorts were evaluated cross-sectionally. Sputum was induced for the assessment of eosinophils. In parallel, blood eosinophil counts, serum periostin concentrations and FENO were assessed. The diagnostic accuracy of these markers to identify eosinophilic asthma (sputum eosinophils 3%) was calculated using receiver operating characteristics area under the curve (ROC AUC).Results In the external validation cohort, ROC AUC for blood eosinophils was 89% (p